A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2011
11/16/2011	CN101879242B Traditional Chinese medicine composition for treating chronic virus b hepatitis through immunity regulation and control
11/16/2011	CN101780185B Health wine for promoting sexual function
11/16/2011	CN101690811B Concentrated freeze-dried yolk antibody composite preparation for infectious bursal disease and preparation process thereof
11/16/2011	CN101632806B Medicinal composition, pill and preparation method thereof
11/16/2011	CN101580755B Process for continuously extracting cordyceps militaris essential oil, cordycepin, cordycepic acid and cordyceps militaris polysaccharide from cordyceps militaris
11/16/2011	CN101407812B Heterologous expression and purification method for human RANTES protein having chemotaxis
11/16/2011	CN101357144B Selaginella uncinata extraction, its preparation method and application
11/16/2011	CN101351477B Anti-CD19 antibodies with reduced immunogenicity
11/16/2011	CN101274963B Anti-cd86 humanized monoclonal antibody
11/16/2011	CN101223177B Water-soluble arteannuin derivant, production method, medicine composition and usage
11/16/2011	CN101185736B Orally-administered traditional Chinese medicine for treating acute lupus erythematosus
11/16/2011	CN101156914B Method for extracting triterpenic acid from Chinese date dregs
11/15/2011	US8058426 Phosphorus-containing compounds and uses thereof
11/15/2011	US8058418 Polynucleotides encoding heavy and light chains of antibodies to OPGL
11/15/2011	US8058400 Composition and method for modulating dendritic cell-t cell interaction
11/15/2011	US8058399 Multispecific reagent for selectively stimulating cell surface receptors
11/15/2011	US8058344 Glycodendrimers having biological activity
11/15/2011	US8058289 Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors
11/15/2011	US8058283 7H-pyrido[3,4-D]pyrimidin-8-ones, their manufacture and use as protein kinase inhibitors
11/15/2011	US8058282 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy
11/15/2011	US8058254 DNA vaccines encoding heat shock proteins
11/15/2011	US8058249 Immunostimulatory nucleic acid molecules
11/15/2011	US8058248 Foot and mouth disease virus vaccine comprising interferons
11/15/2011	US8058025 Methods for determining efficacy of chemotherapeutic agents
11/15/2011	US8058012 Five-helix protein
11/15/2011	US8057825 Krill extracts for treatment of cardiovascular diseases
11/15/2011	US8057803 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
11/15/2011	US8057801 Tick galectin
11/15/2011	US8057800 antiallergens; antibody for patient hypersensitive to peanuts or tree nuts; isolated peptide comprising an Ara h 2 T cell epitope; diagnosing or monitoring the allergenic condition in a mammal
11/15/2011	US8057789 Hematopoietic stem cell culture for use in treatment of blood disorders; regenerative medicine; tissue engineering
11/15/2011	CA2479126C Combination treatments for chemokine-mediated diseases
11/15/2011	CA2476166C Anti-cd20 antibodies and fusion proteins thereof and methods of use
11/15/2011	CA2461989C Method for treating multiple myeloma
11/15/2011	CA2449403C Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
11/15/2011	CA2399480C Haemophilus influenza outer membrane protein and use thereof in vaccination
11/15/2011	CA2385736C Mediators of hedgehog signaling pathways, compositions and uses related thereto
11/15/2011	CA2171761C Eotaxin: eosinophil chemotactic cytokine
11/10/2011	WO2011140295A2 Modulators of notch receptor signaling and methods of use thereof
11/10/2011	WO2011140255A1 Dendritic cell immunoreceptors (dcir)-mediated crosspriming of human cd8+ t cells
11/10/2011	WO2011139988A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of seryl-trna synthetases
11/10/2011	WO2011139986A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases
11/10/2011	WO2011139951A1 Modulators of fatty acid amide hydrolase
11/10/2011	WO2011139738A2 Therapies using zanolimumab to enhance the immune response
11/10/2011	WO2011139488A2 Methods and materials for reducing cardiac xenograft rejection
11/10/2011	WO2011139273A1 4 substituted pyrazolopyrimidines useful as pkc-theta inhibitors
11/10/2011	WO2011138916A1 Polycyclic compound
11/10/2011	WO2011138398A1 Dosage regimen of diaryl sulfide derivatives
11/10/2011	WO2011138393A1 Treatment of autoimmune diseases
11/10/2011	WO2011138354A1 Antibody composition obtained by fractionation of plasma immunoglobulins affinity chromatography on a sambucus nigra affinity column
11/10/2011	WO2011137528A1 Methods and compounds for inhibiting glycosyltransferases
11/10/2011	WO2011120013A9 Vista regulatory t cell mediator protein, vista binding agents and use thereof
11/10/2011	WO2011110918A8 Composition comprising probiotic bacteria for use in the treatment of immune disorders
11/10/2011	WO2011087795A3 Methods of using small compounds to enhance myeloid derived suppressor cell function for treating autoimmune diseases
11/10/2011	WO2011084967A3 Methods and compositions for providing protective immunity in the elderly
11/10/2011	WO2011081489A3 Composition for treating allergic diseases, using wheat bran extract or active ingredient isolated therefrom
11/10/2011	WO2011066390A3 Nanoscale adjuvants and related pharmaceutical compositions and methods
11/10/2011	US20110275827 Mitotic Kinesin Inhibitor
11/10/2011	US20110275680 Noxel oxime derivatives of 3, 5-seco-4-nor-cholestane, pharmaceutical compositions containing same, and method for preparing same
11/10/2011	US20110275678 New Pyridine Derivatives as Leptin Receptor Modulator Mimetics
11/10/2011	US20110275670 New Compounds VII
11/10/2011	US20110275663 N-Acylthiourea and N-Acylurea Inhibitors of the Hedgehog Protein Signalling Pathway
11/10/2011	US20110275659 Tacrolimus For Improved Treatment Of Transplant Patients
11/10/2011	US20110275656 3H-Imidazo [4, 5-C] Pyridine- 6 -Carboxamides As Anti-Inflammatory Agents
11/10/2011	US20110275655 Pyrimidinecarboxamide derivatives as inhibitors of syk kinase
11/10/2011	US20110275645 Small Molecules for Inhibition of Protein Kinases
11/10/2011	US20110275639 C5aR ANTAGONISTS
11/10/2011	US20110275638 Piperazine derivatives and their use as leptin receptor modulators
11/10/2011	US20110275637 Piperazine derivatives and their use as leptin receptor modulators
11/10/2011	US20110275633 2,4-diaminopyrimidine derivates as ptk2- inhibitors for the treatment of abnormal cell growth
11/10/2011	US20110275632 Method for preventing or treating a disease related to the glucocorticoid receptor
11/10/2011	US20110275629 Pyridazino-pyridinone Compounds and Methods of Use
11/10/2011	US20110275627 Indolizine inhibitors of leukotriene production
11/10/2011	US20110275621 Hiv integrase inhibitors
11/10/2011	US20110275615 Novel substituted amides, their preparation and use
11/10/2011	US20110275611 Chemical compounds
11/10/2011	US20110275610 Substituted pyrazole compounds
11/10/2011	US20110275606 Substituted porphyrins
11/10/2011	US20110275604 Aminoalkylsterol compounds with antitumoral and neuroprotective activity
11/10/2011	US20110275587 Topical delivery of viscous medications for the treatment of diseases associated with chronic sinusitis
11/10/2011	US20110275575 Peptide inhibitors of protein kinase c
11/10/2011	US20110275558 Lanthionine synthetase component c-like proteins as molecular targets for preventing and treating diseases and disorders
11/10/2011	US20110274760 Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs
11/10/2011	US20110274757 Nucleic acid delivery vehicle and uses thereof
11/10/2011	US20110274723 Cancer immunotherapy and method of treatment
11/10/2011	US20110274722 Food containing a probiotic and an isolated beta-glucan and methods of use thereof
11/10/2011	US20110274721 Hiv vaccines based on env of multiple clades of hiv
11/10/2011	US20110274720 Capsular gram-positive bacteria bioconjugate vaccines
11/10/2011	US20110274719 Helicobacter system and uses thereof
11/10/2011	US20110274718 System for Modulating Expression of Hypothalmic Brain-Derived Neurotrophic Factor (BDNF)
11/10/2011	US20110274714 Broad Spectrum Vaccine Against Non-Typhoidal Salmonella
11/10/2011	US20110274713 Antigen-presenting scaffolds
11/10/2011	US20110274712 Antigenic compositions
11/10/2011	US20110274711 Hla-g polypeptides and pharmaceutical uses thereof
11/10/2011	US20110274710 Pcv2 immunogenic compositions and methods of producing such compositions
11/10/2011	US20110274705 Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells
11/10/2011	US20110274704 Compositions and Methods of Use of Immunotoxins Comprising Ranpirnase (Rap) Show Potent Cytotoxic Activity
11/10/2011	US20110274699 ANTIBODIES THAT BIND HUMAN PROTEIN TYROSINE PHOSPHATASE beta (HPTPbeta) AND USES THEREOF
11/10/2011	US20110274698 Immunomodulation Of Inflammatory Conditions Utilizing Follistatin-Like Protein-1 And Agents That Bind Thereto
11/10/2011	US20110274696 Antibodies to ccr2
11/10/2011	US20110274685 Antibodies that bind human cd27 and uses thereof

1 ... 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 ... 1172